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Thioredoxin reductase 1 suppresses 
adipocyte differentiation and 
insulin responsiveness
Xiaoxiao Peng1,†, Alfredo Gimé nez-Cassina1,2, Paul Petrus3, Marcus Conrad4, Mikael Rydén3 & 
Elias S. J. Arnér1
Recently thioredoxin reductase 1 (TrxR1), encoded by Txnrd1, was suggested to modulate glucose 
and lipid metabolism in mice. Here we discovered that TrxR1 suppresses insulin responsiveness, 
anabolic metabolism and adipocyte differentiation. Immortalized mouse embryonic fibroblasts (MEFs) 
lacking Txnrd1 (Txnrd1−/−) displayed increased metabolic flux, glycogen storage, lipogenesis and 
adipogenesis. This phenotype coincided with upregulated PPARγ expression, promotion of mitotic 
clonal expansion and downregulation of p27 and p53. Enhanced Akt activation also contributed to 
augmented adipogenesis and insulin sensitivity. Knockdown of TXNRD1 transcripts accelerated 
adipocyte differentiation also in human primary preadipocytes. Furthermore, TXNRD1 transcript levels 
in subcutaneous adipose tissue from 56 women were inversely associated with insulin sensitivity  
in vivo and lipogenesis in their isolated adipocytes. These results suggest that TrxR1 suppresses anabolic 
metabolism and adipogenesis by inhibition of intracellular signaling pathways downstream of insulin 
stimulation.
Adipose tissue plays a major role in energy metabolism, and aberrations in its development or function can lead 
to an array of metabolic alterations and diseases. Up to 90% of the volume of adipose tissue is comprised of adi-
pocytes generated through adipogenesis from specific precursor cells and in adult humans, white adipose tissue 
is in a dynamic state where approximately 10% of the adipocyte pool is turned over annually1. The process of 
adipogenesis requires an orchestrated multistep process of sequentially concerted signaling events, converging 
on activation of key transcription factors required for adipocyte formation. The most critical transcription fac-
tors include members of the CCAAT-enhancer-binding protein (C/EBP) and peroxisome proliferator-activated 
receptor (PPAR) families2,3. Early signaling events mediated by C/EBPβ and C/EBPα contribute to initiate adi-
pogenesis by inducing PPARγ , among others. In addition, they also contribute to maintenance of the adipose 
phenotype3. Activation of the nuclear receptor PPARγ is both necessary and sufficient for differentiation of adi-
pocytes4 and pro-adipogenic or anti-adipogenic factors either induce or repress PPARγ , respectively3. Adipocyte 
differentiation is also closely linked to insulin signaling3. Attenuating insulin signaling, for instance by loss of 
insulin-receptor substrate (IRS) proteins, inhibition of phosphatidylinositol-3 kinase (PI3K) or depletion of AKT/
protein kinase B (PKB), leads to suppression of adipocyte differentiation5–7.
The mammalian selenoprotein thioredoxin reductase 1 (TrxR1), encoded in mice by Txnrd1 and in human 
by TXNRD1, plays a key role in antioxidant defense, redox regulation, cell proliferation and cell signaling events, 
by catalyzing reduction of the active site disulfide of thioredoxin 1 (Trx1) and several other substrates in cells8. 
Germline deletion of Txnrd1 in mice causes early embryonic death9,10. However, hepatocyte-specific conditional 
deletion of Txnrd1 is not lethal, but results in pronounced alterations of glycogen and lipid storage in the liver11,12. 
Although somewhat conflicting data have been published, some observations indicate that TrxR1 can influence 
lipid turnover. Hepatocyte-specific disruption of Txnrd1 was found in one study to cause a metabolic switch in 
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Figure 1. TrxR1 depletion promotes glucose utilization in biosynthetic pathways. (A) Glucose uptake in 
Txnrd1fl/fl and Txnrd1−/− MEFs (n = 3, ± SEM). (B) Glycolytic flux in MEFs, as determined by lactate release to 
the extracellular milieu (n = 3, ± SEM). Given the previously described sensitivity of Txnrd1−/− MEFs to variation 
in extracellular glucose levels, lactate production was measured in conditions of low glucose (5 mM, left panel)  
and high glucose (25 mM, right panel). (C) Mitochondrial respiration in real time in Txnrd1fl/fl and Txnrd1−/− 
MEFs determined by extracellular flux analysis and expressed as oxygen consumption rate (OCR) (n = 6, 
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which hepatic lipogenesis seemed to be repressed and glycogen storage greatly increased11, while another study 
reported mild to severe hepatic accumulation of lipids12. In the study by Iverson and colleagues, lipid content 
was assessed using transmission electron microscopy (TEM) and appeared repressed in periportal hepatocytes 
because of high glycogen accumulation11. In the Carlson study, lipids were assessed using morphological assess-
ments of hepatocyte vacuoles that were judged to resemble lipid vesicles12. Thereby neither of these studies val-
idated fat accumulation by direct measurements of lipid content. Thus, while both studies suggested a role of 
TrxR1 in regulation of glucose and/or lipid metabolism, effects of TrxR1 on lipid metabolism clearly remain to 
be defined.
Here, we first examined the impact of TrxR1 on glucose and lipid metabolism using well-defined cell cul-
ture models optimally suited for studies of molecular mechanisms. Because primary MEFs can be differentiated 
into osteocytes, chondrocytes or adipocytes depending upon choice of hormonal stimuli13, we studied the pro-
pensity of Txnrd1−/− MEFs to undergo adipogenesis and compared this to parental cells expressing the intact 
Txnrd1 gene. We also determined adipocyte differentiation of primary human preadipocytes transfected with 
TXNRD1-targeting or non silencing siRNA oligonucleotides, and analyzed possible correlations of TXNRD1 
transcript levels to clinical parameters in a cohort of obese and non-obese women. Our results collectively suggest 
that TrxR1 exerts a hitherto unknown but potent role in regulation of insulin responsiveness and adipogenesis.
Results
Txnrd1 deletion leads to altered glucose handling in immortalized mouse embryonic fibro-
blasts. The Txnrd1−/− MEFs used herein were previously characterized in detail and confirmed to completely 
lack TrxR1 expression while, in contrast, the parental Txnrd1fl/fl MEFs have a TrxR activity of ≈ 25 nmol/min/mg 
protein14,15. Both cell types are immortalized batches of MEF, where the Txrnd1−/− genotype was obtained by 
ex vivo treatment of the Txnrd1fl/fl cells with Tat-Cre14,15. Here we observed that glucose uptake and glycolytic flux 
were not affected by deletion of TrxR1 (Fig. 1A,B). However, basal mitochondrial respiration rates in the presence 
of glucose, but not maximal respiration or unproductive (non-ATP coupled) oxygen consumption, were signif-
icantly increased in Txnrd1−/− MEFs (Fig. 1C), indicating higher metabolic flux without increased mitochon-
drial capacity or any apparent mitochondrial dysfunction. The increase in basal mitochondrial respiration was 
not due to an expansion in mitochondrial mass, which was comparable between Txnrd1fl/fl and Txnrd1−/− cells 
(Fig. 1D,E). Strikingly, increased mitochondrial respiration in Txnrd1−/− cells was furthermore not correlated 
with higher steady-state ATP levels (Fig. 1F). This led us to hypothesize that the elevated metabolic flux in absence 
of TrxR1 was geared towards anabolic biosynthetic processes. Indeed, we observed that the Txnrd1−/− cells con-
tained significantly higher levels of glycogen (Fig. 1G) as well as triglycerides (Fig. 1H) compared to Txnrd1fl/fl 
MEFs.
The absence of TrxR1 facilitates adipocyte differentiation of immortalized mouse embryonic 
fibroblasts. The significantly higher content of triglycerides in Txnrd1−/− MEFs showed that Txnrd1 dele-
tion facilitated fat accumulation. Remarkably, cultures of Txnrd1−/− MEFs, unlike Txnrd1fl/fl, displayed a readily 
observable proportion of cells with adipocyte-like morphology containing small lipid droplets as confirmed by 
Oil Red-O staining (Fig. 2A,B). We therefore asked whether the enhanced ability of Txnrd1−/− MEFs to store 
fat could correlate with an increased propensity for differentiation into adipocytes. To test this hypothesis, we 
attempted to induce adipogenic differentiation by hormonal induction using a well-established combination of 
pro-adipogenic factors (DMI: dexamethasone, methylisobutylxanthine and insulin, together with rosiglitazone). 
Indeed, Txnrd1−/− MEFs displayed evident signs of adipocyte differentiation, which were not observed in the 
parental cells (Fig. 2A–C).
Because PPARγ and C/EBPα are crucial transcriptional activators in adipogenesis, we next analyzed their 
levels in the Txnrd1−/− and Txnrd1fl/fl MEFs. We found that both PPARγ and C/EBPα were readily detected in 
Txnrd1−/− cells and further elevated by adipogenic induction, whereas their expression levels were much lower 
in the parental Txnrd1fl/fl cells (Fig. 2D). We also examined the expression of adipocyte fatty-acid-binding pro-
tein 4 (FABP4/aP2), which is a widely used adipogenic marker16. Pronounced expression of FABP4/aP2 was 
found in hormonally induced Txnrd1−/− MEFs, but neither in the untreated Txnrd1−/− cells nor in the parental 
Txnrd1fl/fl MEFs irrespective of hormonal treatment (Fig. 2D). Uncoupling protein 1 (UCP1) was also sponta-
neously expressed in the Txnrd1−/− cells, and upregulated in both knockouts and parental cells after hormonal 
induction but to a higher extent in the Txnrd1−/− MEFs (Fig. 2D). These results show that Txnrd1−/− MEFs has a 
more efficient adipogenic program compared to immortalized wild type Txnrd1fl/fl MEFs.
± SEM), depicted in the top panel. The sequential addition of the mitochondrial ATP synthase inhibitor 
oligomycin, the uncoupling agent Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) and the 
respiratory complex III inhibitor antimycin allowed us to determine basal mitochondrial respiration (bottom 
panel, left), maximal respiratory capacity (bottom panel, middle) and “leak”, or non-ATP coupled respiration 
(bottom panel, right) (D,E) Mitochondrial content in Txnrd1fl/fl and Txnrd1−/− MEFs as determined through 
levels of the mitochondrial protein voltage-dependent anion channel (VDAC1; (D) see Supplementary Material 
for non-cropped immunoblots) and by relative fluorescence intensity (Relative Fluorescent Units, RFU) yielded 
by the non-potentiometric mitochondrial fluorescent probe MitoTracker Green (E). (F) ATP levels in Txnrd1fl/fl 
and Txnrd1−/− MEFs in steady state, expressed as Relative Luminescent Units (RLU) (n = 8, ± SEM).  
(G) Intracellular glycogen levels in Txnrd1fl/fl and Txnrd1−/− MEFs. (F) Intracellular Triglyceride levels 
Txnrd1fl/fl and Txnrd1−/− MEFs. (* p < 0.05; * * p < 0.01).
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As we did not observe adipocyte differentiation of the parental Txnrd1fl/fl MEFs, possibly due to the immortal-
ization process that is well known to deprive MEFs of their potential to undergo adipogenesis3, we also analyzed 
freshly isolated primary MEFs and compared them with the Txnrd1−/− MEFs. This demonstrated that, unlike the 
immortalized Txnrd1fl/fl MEFs, primary MEFs were indeed able to differentiate into adipocytes, but only after a 
very long period of hormonal induction (23 days). Adipocyte differentiation of the Txnrd1−/− MEFs was thus 
clearly enhanced compared also to primary MEFs, as illustrated by their stronger Oil Red-O staining and higher 
Figure 2. Txnrd1 depletion increases lipogenesis and promotes adipocyte differentiation of mouse 
embryonic fibroblasts. (A) MEFs were hormonally induced to trigger adipocyte differentiation (DMI + Rosi; 
see Methods for details) and on day 8, the cells were imaged with 20x magnification; left column are untreated 
controls at day 8, right column are hormonally induced cells. (B) The same cells as shown in A were stained 
with Oil Red-O and shown are photos of the entire petri dishes; The arrow points toward an image with 20x 
magnification displaying the Oil Red-O-stained adipocytes formed in Txnrd1−/− MEFs. (C) The Oil Red-O 
staining was extracted from plates as shown in B and the color intensity was measured (n = 4–8, ± SEM). 
Significant differences between Txnrd1fl/fl and Txnrd1−/− MEFs in the control samples are indicated (* * P < 0.01) 
as well as in the hormonally treated samples (##P < 0.01). (D) The cell lysates of MEFs treated as in B were 
immunoblotted with antibodies against PPARγ , C/EBPα , FABP4/aP2 and UCP1. Positions of molecular weight 
markers (kDa) and the sizes of the analyzed proteins are as indicated. Ponceau S staining of the membrane 
was used as protein loading control (right). (E) The different MEFs were induced to adipocyte differentiation 
for the time indicated. Oil Red-O staining with 20x magnification was used to image the formed adipocytes. 
(F) The cell lysates of the MEFs in E were immunoblotted with antibody against FABP4/aP2, as indicated. The 
symbol “* ” indicates an unidentified band approximately twice the size of FABP4/aP2. Ponceau S staining of 
the membrane was used as loading control (right). (G) Cellular TrxR activity in extracts of the indicated MEF 
cultures was measured at different time points during the adipocyte differentiation process. The arrow indicates 
the initiation of adipocyte differentiation using hormonal treatment.
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levels of FABP4/aP2 expression (Fig. 2E,F). Enzymatic activity assays on cell lysates harvested at different time 
points showed that cellular TrxR activity levels correlated inversely with the adipocyte differentiation capability 
of these cell types, with Txnrd1fl/fl MEFs having 2-fold higher basal TrxR activity than primary MEFs, while the 
knockout cells only retained background activity, most likely representing mitochondrial thioredoxin reductase 
(TrxR2) activity15 (Fig. 2G).
Txnrd1 deletion accelerates mitotic clonal expansion and enhances insulin responsiveness 
upon induction of adipocyte differentiation. Post-confluent and growth-arrested pre-adipocytes 
Figure 3. Txnrd1 depletion causes accelerated mitotic clonal expansion and sensitizes MEFs to insulin 
signaling upon adipocyte differentiation induction. (A) Txnrd1fl/fl and Txnrd1−/− MEFs were either kept 
in culture two days after reaching confluency or hormonally induced to adipocyte differentiation as indicated 
and described in the text. Total cell numbers at different time points were counted and then plotted as shown 
(n = 4, ± SEM). Left panel are untreated controls with the right panel showing the hormonally induced 
cells. (B) The lysates of cells obtained at the different time points shown in (A) were immunoblotted using 
antibodies against C/EBPβ and cyclin A, with immunoblotting for GAPDH used as loading control. Sizes 
of the LAP and LIP forms of C/EBPβ are indicated. (C) Txnrd1fl/fl and Txnrd1−/− MEFs were hormonally 
induced for adipocyte differentiation and analyzed at different time points as indicated. The cell lysates 
were immunoblotted with antibodies against pAkt (Thr308), pAkt (Ser473), total Akt, pCREB, pATF1, pS6 
or total S6, with immunoblotting of GAPDH used as loading control. Only the parts of the membranes 
corresponding to the expected sizes of the target proteins are shown. (D) Txnrd1fl/fl and Txnrd1−/− MEFs were 
treated for hormonal induction of adipocyte differentiation for 10 min, whereupon cell lysates were used for 
immunoprecipitation with an antibody against insulin receptor β subunit. The pulled down samples were 
subsequently immunoblotted with antibodies against the insulin receptor β subunit (left) and phosphotyrosine 
(PY)-containing proteins (right), as indicated. See Supplementary Material for non-cropped immunoblots.
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reenter the cell cycle to undergo two sequential rounds of mitosis following hormonal induction of differentia-
tion, which is referred to as mitotic clonal expansion (MCE)17, a necessary step for adipogenesis in MEFs18. Here 
we found that the cell number in Txnrd1−/− MEF cultures, in the absence of hormonal induction, still increased 
after reaching confluence to almost 2-fold after 96 h (Fig. 3A, left panel). Cell number was further increased upon 
hormonal induction of adipocyte differentiation (Fig. 3A, right panel). In contrast, there was no cell proliferation 
beyond confluency in Txnrd1fl/fl MEFs, irrespective of hormone treatment (Fig. 3A). In agreement with these 
cellular phenotypes, the MCE-related transcription factor CCAAT-enhancer-binding protein β (C/EBPβ )18 was 
highly induced in Txnrd1−/− MEFs following induction of differentiation, while this increase was much less pro-
nounced in the parental cells (Fig. 3B). Interestingly, both the adipogenesis promoting (LAP, liver-enriched acti-
vator protein) and antiadipogenic (LIP, liver-enriched inhibitory protein) isoforms of C/EBPβ 19 were increased 
in Txnrd1−/− MEFs, but at the early time points LAP was more increased than LIP (Fig. 3B). Strong upregulation 
of cyclin A at 24 h after induction in the knockout cells, but not in the parental cells, was in agreement with the 
finding that only Txnrd1−/− MEFs traversed the G1-S checkpoint after having reached confluency (Fig. 3B). These 
findings suggest that TrxR1 negatively regulates adipogenesis by facilitating contact inhibition and suppression 
of MCE.
Because insulin signaling has strong modulatory effects on adipogenesis we next analyzed the phosphoryla-
tion status of key intracellular phosphorylation cascade proteins linked to insulin signaling. The serine/threonine 
kinase Akt (also known as protein kinase B, PKB) is involved in most of the metabolic actions of insulin20. Here, 
we observed a transiently enhanced phosphorylation of Akt at residues Thr308 and Ser473 within the first hour 
after hormonal induction of differentiation, which was more pronounced in Txnrd1−/− MEFs compared to the 
parental cells (Fig. 3C). Phosphorylation of cyclic AMP response element–binding protein (CREB), which is 
linked to Akt activation21 and important for adipogenesis signaling22, revealed no major difference between the 
two MEFs except for a slightly more sustained expression in Txnrd1fl/fl cells at the 120 min time point (Fig. 3C). 
However, activating transcription factor 1 (ATF1), which is closely related to CREB and shares similar functional 
motifs23, was more phosphorylated in Txnrd1−/− MEFs after hormonal induction of differentiation (Fig. 3C). 
Another effector of insulin action involved in adipogenesis is mTOR124, the activity of which is illustrated by the 
levels of phosphorylation of its downstream target ribosomal protein S625. Intriguingly, we found that the baseline 
phosphorylation level of S6 was lower in Txnrd1−/− MEFs compared to the parental cells, but more responsive 
with strongly increased phosphorylation upon induction of differentiation (Fig. 3C). These results collectively 
demonstrate clearly enhanced intracellular insulin responsiveness after deletion of the Txnrd1 gene.
Previous studies have shown that the Trx system helps to reduce and thus activate oxidized protein-tyrosine 
phosphatase 1B (PTP1B) in relation to PDGF signaling26. Because PTP1B is an important negative regulator also 
of insulin signaling, as it dephosphorylates key tyrosine residues of the insulin receptor (IR)27, we next assessed 
IR phosphorylation status. We observed no major difference in phosphorylation of tyrosine residues on IR when 
comparing parental and Txnrd1−/− MEFs after rosiglitazone treatment, with similarly increased phosphorylation 
of IR in both cell types (Fig. 3D). This suggests that the difference in insulin responsiveness between Txnrd1−/− 
and Txnrd1fl/fl MEFs should be explained by signaling events downstream of IR activation, which was analyzed 
next.
Txnrd1 deletion sensitizes cells to insulin signaling by attenuating PTEN activity. Insulin sig-
naling requires phosphatidylinositol (PI) 3-kinase (PI3K)-mediated phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) generation, which in turn activates Akt/PKB and this process is negatively regulated by the phosphatase 
and tensin homologue (PTEN) protein20. Here we found that PTEN protein levels were lower in Txnrd1−/− cells 
compared to the parental Txnrd1fl/fl MEFs (Fig. 4A). Many factors are known to regulate PTEN expression, 
including p5328 that upregulates PTEN at both the mRNA and protein levels29,30. In mammalian cells, TrxR inhi-
bition was shown to impair p53 conformation and function31, which prompted us to analyze p53 levels in our cell 
models. Interestingly, p53 was hardly detectable in Txnrd1−/− MEFs, regardless of stages of cell growth or upon 
doxorubicin treatment, which normally increases p53 expression. In contrast, p53 levels were clearly responding 
in Txnrd1fl/fl MEFs with a higher expression during proliferation or upon doxorubicin treatment (Fig. 4B,C). It is 
thus possible that p53 can contribute to the higher PTEN levels in Txnrd1fl/fl cells compared to Txnrd1−/−, but it 
is known that PTEN can also be regulated by several different mechanisms.
It was reported that Trx1 can bind to and inhibit PTEN in a redox dependent manner, which may result in 
activated Akt32, but, conversely, Trx1 can also reduce oxidized PTEN to increase its activity33,34. We therefore 
investigated the levels of Trx1 as well as its redox status. We first confirmed that Trx1 protein levels are upregu-
lated in Txnrd1−/− MEFs upon hormonal treatment (Fig. 4D), as reported previously for the regularly propagated 
cells15. In our earlier study, we showed that Trx1 was mostly present in its reduced form in Txnrd1−/− cells, unless 
the cells were challenged with exaggerated oxidative stress15. Here we found that Trx1 was maintained mostly 
in its reduced form in Txnrd1−/− MEFs also after hormonal induction of adipocyte differentiation (Fig. 4E). 
Co-immunoprecipitation studies furthermore showed that a physical interaction between Trx1 and PTEN could 
be detected in Txnrd1−/− cells, but not in the parental MEFs (Fig. 4F,G). Taken together, these results would be 
compatible with Trx1-mediated binding to and inhibition of PTEN in the Txnrd1−/− cells, which may further 
contribute to their sensitization to insulin signaling. To examine this possibility, we transiently overexpressed 
wildtype (wt) PTEN, or its inactive C124S mutant derivative, in the Txnrd1−/− MEFs. This showed that over-
expression of wt PTEN counteracted the adipogenesis of Txnrd1−/− cells, as illustrated by lower levels of the 
adipocyte marker FABP4/aP2 and less Oil Red-O stained lipid accumulation, with no major effects on PPARγ 
levels (Fig. 4H). Collectively, these findings suggest that attenuated PTEN activity due to lower PTEN levels and 
inhibitory binding of Trx1 should be a part of the molecular mechanisms explaining the augmented adipogenesis 
observed in Txnrd1−/− MEFs.
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Figure 4. Attenuated cellular PTEN activity contributes to insulin sensitization and adipogenesis in Txnrd1−/− 
MEFs. (A) Lysates of Txnrd1fl/fl and Txnrd1−/− MEFs were immunoblotted with an antibody against PTEN, using 
GAPDH as loading control. (B) Txnrd1fl/fl and Txnrd1−/− MEFs were cultured into different stages of confluency, 
and lysates were immunoblotted with an antibody against p53, using GAPDH as loading control. (C) Txnrd1fl/fl and 
Txnrd1−/− MEFs were cultured to 100% confluency and then treated 24 h with doxorubicin as indicated. Lysates 
were immunoblotted with an antibody against p53 using Ponceau S staining as loading control. (D) Txnrd1fl/fl and 
Txnrd1−/− MEFs were induced for hormonal adipocyte differentiation for the indicated time, and lysates were 
immunoblotted with an antibody against Trx1. (E) Txnrd1fl/fl and Txnrd1−/− MEFs were induced to adipocyte 
differentiation with time points as indicated and the redox state of Trx1 was analyzed by redox immunoblotting15. 
Lysates of Txnrd1fl/fl and Txnrd1−/− MEFs cultured at low density (LD, 1000 cells/cm2) for 20 h in high glucose 
medium15 were used as negative and positive controls for Trx1 oxidation, respectively. Migration of Trx1 in a 
standard curve of MEF lysate treated so that Trx1 variants in all forms from 0 to 6 free Cys thiol (-SH) groups being 
present70 is shown in the last lane. (F) Lysates of Txnrd1fl/fl and Txnrd1−/− MEFs were immunoprecipitated with 
an antibody against PTEN and then immunoblotted with an antibody against either PTEN (left) or Trx1 (right), 
with three repeats for each cell line or controls without cell lysate or antibody against PTEN as indicated. (G) Band 
intensities in F were quantified with the ratio between Trx1 and PTEN plotted (n = 3, ± SEM) and significant 
difference indicated (* P < 0.05). (H) Confluent Txnrd1−/− MEFs transfected for expression of PTEN variants as 
indicated were induced with adipocyte differentiation treatment. Lysates were subsequently immunoblotted with 
antibodies against PPARγ or FABP4/aP2, with Ponceau S staining as loading control. Oil Red-O staining after 
differentiation was also extracted with color intensity measured (n = 4–8, ± SEM). Significant differences against 
cells transfected with empty vector pSG5L are indicated (n.s. no significant difference; * * P < 0.01).
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NAC supplementation blocks adipogenesis in Txnrd1−/− MEFs. Since physiological increases in 
H2O2 levels have been proposed as important triggers of adipocyte differentiation35 and because we found earlier 
that Txnrd1−/− MEFs present higher levels of H2O215, we next investigated if supplementation with antioxidants 
could blunt the increased adipogenesis process in these cells. Indeed, PEG-catalase and α -tocopherol attenuated 
adipocyte formation and lipid accumulation. Strikingly, N-acetyl cysteine (NAC) supplementation completely 
abolished adipogenesis in Txnrd1−/− MEFs (Fig. 5A,B). None of these treatments affected the expression levels of 
PPARγ (Fig. 5C). However, in agreement with lower adipogenesis capability (Fig. 5A), the treatments inhibited 
FABP4/aP2 expression, with NAC totally abrogating its expression (Fig. 5C). We furthermore found that NAC did 
not increase, but rather decreased, the total glutathione (GSH + GSSG) levels in Txnrd1−/− MEFs, although these 
were still higher than in the parental Txnrd1fl/fl MEFs (Fig. 5D). Thus, the blocking effects of NAC were not nec-
essarily due its function as a cysteine and GSH precursor, and could involve several of the other reported effects 
of NAC supplementation36. We further found that NAC, but not PEG-catalase, almost completely abolished the 
capacity for MCE of Txnrd1−/− MEFs (Fig. 5E), which should be part of the explanation how NAC completely 
inhibited adipogenesis in these cells. However, neither NAC nor PEG-catalase affected C/EBPβ expression after 
Figure 5. NAC treatment blocks adipocyte differentiation of Txnrd1−/− MEFs. (A) Confluent Txnrd1−/− 
MEFs were pretreated with 2 mM NAC, 100 U/ml PEG-catalase or 100 μ M α -tocopherol for two days, before 
induction with standard adipocyte differentiation treatment and keeping the antioxidants present throughout 
the treatment for 8 days. The cells were subsequently stained with Oil Red-O; here 5x magnification was used for 
imaging. (B) The Oil Red-O staining was extracted and the color intensity was measured (n = 8, ± SEM), with 
significant differences between untreated controls and treated samples indicated (* * * P < 0.05). (C) Lysates of the 
MEFs in A were immunoblotted with antibodies against PPARγ and FABP4/aP2, with Ponceau S staining used 
as loading control. (D) GSH + GSSG levels (total GSH) were measured in Txnrd1fl/fl, untreated or 2 mM NAC 
treated Txnrd1−/− MEFs for time points as indicated (n = 3, ± SEM). Significant differences between untreated 
Txnrd1−/− MEFs and the other samples are indicated (* P < 0.05). (E) Confluent Txnrd1−/− MEFs were pretreated 
with 2 mM NAC or 100 U/ml PEG-catalase for two days, before they were induced with adipocyte differentiation 
treatment with the antioxidants present. Cell numbers at different time points after induction were determined 
and plotted (n = 4, ± SEM). (F) The cell lysates of the different time points in E were immunoblotted with 
antibodies against C/EBPβ and cyclin A, with GAPDH as loading control. (G) Confluent Txnrd1−/− cells were 
incubated with 2 mM NAC for two days and then induced with adipocyte differentiation treatment as described 
for indicated time points in the NAC treated samples. Txnrd1fl/fl and Txnrd1−/− cells not treated with antioxidants 
were used for comparison. The mRNA levels of p27 and cyclin E at different time points were measured using real 
time-PCR and plotted by normalizing to 18 S (n = 3, ± SEM). (H) The cell lysates of the MEFs at different time 
points between day 2 (D2) and day 4 (D4) cultured as in (G) were immunoblotted with antibodies against p27, 
cyclin E, pAkt (S473) and total Akt, with GAPDH used as loading control. See Supplementary Material for non-
cropped immunoblots.
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hormonal induction (Fig. 5F). Upregulation of cyclin A in Txnrd1−/− MEFs was however attenuated by NAC 
treatment, which agrees with its blocking effect on MCE (Fig. 5F).
We next investigated NAC effects on transcription levels of cyclin-dependent kinase inhibitors and cyclins. 
This revealed that p27, an inhibitor of cell cycle progression37, was downregulated during initiation of adipocyte 
differentiation in Txnrd1−/− MEFs compared to parental cells, but that NAC treatment attenuated the fluctuations 
in its transcript levels at later time points (Fig. 5G). Conversely, the transcript levels of cyclin E were higher in 
Txnrd1−/− MEFs and increased to a larger extent on day 3 compared to Txnrd1fl/fl MEFs, with NAC partially atten-
uating this difference (Fig. 5G). To further validate these findings, we analyzed the protein levels of p27 and cyclin 
E at different time points between day 2 and day 4 after hormonal induction of adipogenesis (Fig. 5H). Reflecting 
the effects on mRNA levels, the p27 protein levels were much lower in Txnrd1−/− compared to Txnrd1fl/fl MEFs 
and further decreased on day 3, whereas NAC treatment increased the p27 protein levels in these cells (Fig. 5H). 
Cyclin E was also higher in the knockout MEFs compared to parental cells, with NAC slightly lowering its expres-
sion towards the later time points (Fig. 5H). Akt activation has been reported to depress, both directly and indi-
rectly, the expression levels of p2738,39. Here we indeed found that Akt was more activated in the knockout cells, as 
indicated by phosphorylation of its Ser473 residue, while NAC prevented this activation (Fig. 5H).
Extensive activation of PPARγ in Txnrd1−/− MEFs. We next found that Txnrd1−/− MEFs displayed as 
much as 30-fold higher basal PPARγ expression levels than the parental cells, which were further elevated upon 
adipocyte differentiation. NAC treatment somewhat inhibited upregulation of PPARγ levels in the initial days 
of the differentiation process, but not nearly down to the levels found in the parental cells (Fig. 6A). Not only 
PPARγ expression levels but also extent of activation can thereby contribute to the observed phenotypes, which 
we studied next.
Nitration modified unsaturated fatty acids are endogenous PPARγ ligands that can be induced upon oxidative 
stress40,41. We thus next assessed lipid peroxidation levels in our cell models using a Bodipy (581/591) reagent. 
Txnrd1−/− MEFs had six times higher levels of lipid peroxides compared to Txnrd1fl/fl MEFs, which were to some 
extent dampened by treatment with the lipid soluble antioxidant α -tocopherol. Treatment with NAC, in contrast, 
failed to reduce lipid peroxidation in the knockout MEFs but instead increased the signal (Fig. 6B). These find-
ings suggested that the very high expression of PPARγ together with higher lipid peroxide levels could provide 
a mechanism for increased adipogenic potential of Txnrd1−/− MEFs, but the potential involvement of nitrated 
lipids and their possible prevention by NAC was still unclear.
To investigate direct effects of nitro-modified unsaturated fatty acids, we attempted to stimulate differentiation 
of the Txnrd1−/− MEFs using either 9-Nitrooleate (AONO2) or 10-Nitrolinoleate (LNO2) instead of using the 
Figure 6. Extensive upregulation of PPARγ expression in Txnrd1−/− MEFs. (A) The mRNA levels of PPARγ 
in Fig. 4G were measured using real time-PCR and plotted as normalized to 18 S (n = 3, ± SEM). (B) Lipid 
peroxidation in Txnrd1fl/fl, Txnrd1−/− and Txnrd1−/− MEFs treated with 100 μ M α -tocopherol or 2 mM NAC 
for two days was assessed using Bodipy (581/591) staining. Bodipy oxidation was analyzed by FACScan in the 
FITC channel. Mean fluorescence intensity (MFI) was plotted (n = 3–4, ± SEM), with significant differences 
between untreated Txnrd1−/− MEFs and the other samples indicated (* P < 0.05). (C) Txnrd1−/− MEFs were 
induced to adipocyte differentiation using DMI, DMI plus 3 μ M AONO2, LNO2 or Rosiglitazone respectively 
as described for 8 days. The cell lysates were subsequently immunoblotted with antibodies against PPARγ or 
FABP4/aP2, with Ponceau S staining used as loading control. (D) 130 μ M NAC was incubated with the indicated 
concentration of AONO2, LNO2 or Rosiglitazone respectively for 30 min. Then, the level of free thiols of NAC 
was detected by adding DTNB and measuring the absorbance at 412 nm (n = 3, ± SEM).
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standard PPARγ ligand rosiglitazone in the hormonal induction cocktail. Interestingly, treatment of Txnrd1−/− 
MEFs with dexamethasone, methylisobutylxanthine and insulin alone (DMI) increased expression of PPARγ 
and FABP4/aP2, while addition of AONO2, but not of LNO2, further promoted adipocyte formation as illustrated 
by increased FABP4/aP2 expression (Fig. 6C). Notably, neither of these two compounds upregulated the PPARγ 
expression levels more than DMI treatment alone (Fig. 6C). These findings agree with the notion that AONO2 
directly activates PPARγ as a ligand40. Because nitro-modified unsaturated fatty acids are highly electrophilic 
and can interact directly with free thiols42 we asked whether NAC, having a readily accessible thiol group, might 
directly scavenge these electrophilic metabolites. If so, that could potentially block adipocyte differentiation as 
a result of inhibited PPARγ activation. Indeed, both AONO2 and LNO2, but not rosiglitazone, were found to 
readily react with the free thiol group of NAC at roughly stoichiometric amounts upon 30 min incubation in vitro 
(Fig. 6D). If such direct scavenging would occur also in of Txnrd1−/− MEFs, this should likely contribute to the 
antiadipogenic effect of NAC treatment.
TXNRD1 knockdown promotes adipogenesis of human primary cells. To probe if TrxR1 expres-
sion counteracts adipogenesis also in primary human cells, we isolated stroma vascular cells from abdominal 
subcutaneous adipose tissue that were subsequently cultured and induced to differentiate in vitro. Following 
hormonal induction (DMI + Rosi), we found that cells treated with siRNA-mediated TXNRD1 knockdown sig-
nificantly increased their adipogenesis, as demonstrated by a stronger Oil Red-O staining, compared to cells that 
had been transfected with non-silencing siRNA. This was seen with cells from two different donors and either 
with or without selenium supplementation to the growth medium (Fig. 7A–C).
Figure 7. TXNRD1 knockdown promotes adipogenesis in human pre-adipocytes. (A) Left panel, pre-
adipocytes isolated from donor 1 were cultured with additional of 50 nM selenite, transfected with scramble 
siRNA or with siRNA against TXNRD1, with mRNA levels of TXNRD1 in these cells measured using real time-
PCR and plotted as normalized to LRP10 (n = 3, ± SEM). Right panel, the same treated cells were induced for 
adipocyte differentiation for 6 days. Thereafter, the PPARγ agonist was removed from the medium and the cells 
were incubated for additional 5 days before Oil Red-O staining; 4x magnification was used for imaging. (B) Pre-
adipocytes isolated from donor 2 were plated without selenite supplementation, and subsequently treated and 
analyzed the same way as described in A; 10x magnification was used for imaging. (C) Oil Red-O staining in 







KITT (% fall in P-glucose/min at 4–16 min) − 0.44 0.0079 (* * ) − 0.36 0.030 (* )
P-TG (mM)b 0.18 0.22 (n.s.) 0.34 0.025 (* )
Fat cell lipogenesis (max insulin stimulated/107 cells × 2 hrs)b − 0.38 0.0083 (* * ) − 0.31 0.032 (* )
Adiponectin secretion (ng/107 cells × 2 hrs)b 0.11 0.50 (n.s.) 0.37 0.027 (* )
Table 1.  Relationship between TXNRD1 expression and insulin resistance in vivo and in vitro. TXNRD1 
expression in subcutaneous adipose tissue from 56 individuals was determined by gene micro array and 
analyzed for possible correlation with clinical parameters. Multiple regression analysis was performed 
with TXNRD1 and BMI set as Independent regressors with the listed parameters as dependent regressors. 
Standardized beta coefficients and p-values for the two independent regressors are displayed. aSignificance in 
p-values are indicated (* * p-value < 0.01; * p-value < 0.05; n.s. = no significance, i.e. p-value > 0.05). bFor plasma 
triglycerides, fat cell lipogenesis and adiponectin secretion in vitro, values were log10 transformed to obtain 
normal distribution.
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TXNRD1 transcript levels associate with human insulin resistance in vivo. To assess whether 
TXNRD1 expression in adipose tissue could be related to clinical and/or adipocyte-specific aspects of insu-
lin sensitivity, we analyzed data from a global transcriptional profiling study in 56 women (30 obese and 26 
non-obese)43. We found that TXNRD1 levels correlated with body mass index (BMI, r = 0.56, p < 0.0001). Thus, 
to avoid a bias for BMI as a confounding factor, multiple regression analyses were performed. This revealed that 
TXNRD1 transcript levels in adipose tissue were inversely associated with in vivo measures of insulin responsive-
ness (determined with an intravenous insulin tolerance and plasma glucose reduction test), as well as adipocyte 
responsiveness to insulin in vitro (determined as insulin-stimulated lipogenesis at maximal effective concentra-
tion). Notably, these relationships were specific for insulin responsiveness as there were no BMI-independent 
correlations between TXNRD1 and other measures of lipid or adipocyte metabolism such as e.g. plasma triglyc-
eride levels or adiponectin secretion (Table 1). These findings revealed that, similarly to our findings in the MEF 
cell models, TXNRD1 expression levels correlated with insulin responsiveness and lipogenesis also in this human 
cohort.
Discussion
We recently found that MEFs lacking TrxR1 (Txnrd1−/−) undergo massive cell death when cultured at low density 
(< 1000 cells/cm2) in high-glucose medium, due to impaired self-sufficient growth and insufficient elimination 
of glucose-derived H2O215. However, when cultured at higher density (> 8000 cells/cm2) these cells grow well due 
to a release of catalase activity to the medium sufficient to detoxify their higher levels of metabolism-derived 
H2O215. Txnrd1−/− cells could thus be utilized herein as a well-defined cell culture model system for in-depth 
investigations concerning metabolic consequences of TrxR1 removal. Here we demonstrated that Txnrd1 dele-
tion channels glucose usage towards increased basal mitochondrial respiration and anabolic pathways, result-
ing in increased glycogen and lipid biosynthesis. The differences in basal mitochondrial respiration but not in 
spare respiratory capacity could be due to effects on respiratory complex assembly or perhaps redox-derived 
post-translational modifications of respiratory subunits. Interestingly, recent evidence has shown how oxida-
tive stress can trigger signaling pathways that modulate respiratory rates44. Our results clearly warrant further 
research to delineate the role of TrxR1 in regulating mitochondrial respiration. We also showed that deletion 
or knockdown of TrxR1 strongly improves the capacity of immortalized MEFs or human pluripotent primary 
cells to undergo adipogenesis. The highly significant inverse association between TXNRD1 transcript levels in 
human adipose tissue and insulin responsiveness in vivo and in vitro suggests that our findings have relevance for 
human physiology. From our more detailed analyses of Txnrd1−/− MEFs, insights with regards to the molecular 
mechanisms involved could be gained. These mechanisms are graphically summarized in Fig. 8 and discussed 
further as follows.
Insulin-triggered intracellular signaling cascades are known to play essential roles in adipocyte differentia-
tion3. Our findings of stronger activation of Akt and CREB/ATF1 in the Txnrd1−/− MEFs correlate well with a 
more pronounced adipocyte differentiation phenotype being accentuated by exaggerated insulin signaling. As 
the phosphotyrosine phosphatase PTP1B is known to be an important negative regulator of insulin signaling by 
catalyzing dephosphorylation of IR27, and because PTP1B is reduced and activated by the TrxR1-dependent Trx 
system26, we were initially surprised not to detect any significant differences in IR phosphorylation status between 
Txnrd1−/− and Txnrd1fl/fl MEFs. One explanation might be that in the previous study where the Trx system was 
Figure 8. Signaling mechanisms triggering adipogenesis in MEFs lacking Txnrd1. These schemes 
graphically summarize our findings as reported herein regarding signaling pathways in (A) Txnrd1fl/fl 
functionally wildtype MEFs compared to (B) Txnrd1−/− knockout cells that contribute to increased 
adipogenesis in the latter. Stimulatory signaling pathways are indicated with green arrows while inhibitory 
mechanisms are shown with red block arrows. Note that many of these pathways may be indirect, rather than 
direct as simplified in these schemes. Thicker arrows and bold font suggest increased activities. Processes 
(rather than proteins or molecules) are indicated in italics, with MCE being “mitotic clonal expansion”. Note 
the increased Akt activity in Txnrd1−/− MEFs that together with PPARγ activation and increased oxidative 
stress (indicated by H2O2 and AONO2) triggers increased adipogenesis, which may be counteracted by NAC 
treatment. The mechanisms indicated in these schemes are further discussed in the text.
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found to act in PTP1B activation, Txnrd1−/− MEFs were starved for 24 h using 1% FBS and thereupon induced 
with platelet-derived growth factor (PDGF)26. Starvation is well known to induce oxidative stress and may thus 
have exaggerated PTP1B oxidation in the absence of TrxR1. Also, here we studied IR status and not the PDGF 
receptor and the exact ligand-receptor mediated phosphorylation cascades where the Trx system-catalyzed acti-
vation of PTP1B is important need to be further studied. Our findings in the present study however strongly sug-
gest that the increased capacity for adipocyte differentiation of MEFs upon Txnrd1 deletion should be explained 
by accumulated effects of several altered signaling events downstream of IR that lead to increased insulin respon-
siveness. Such effects are likely to contribute to the inverse correlation between TXNRD1 transcription and clin-
ical parameters of insulin action as found in our human cohort of obese and non-obese women, even though 
detailed mechanistic studies must be performed also with human cells and tissues before such assumptions can 
be fully confirmed.
Our finding that the expression level of the negative Akt regulator PTEN was lower in the TrxR1 deficient 
MEFs should be important for the observed phenotype, with the PI3K/Akt axis being crucial for insulin triggered 
adipogenesis45. Further studies are needed to validate whether the low p53 levels in Txnrd1−/− cells are an impor-
tant factor explaining their propensity to differentiate. That would fit with earlier observations that p53 can be an 
efficient suppressor of white adipocyte differentiation46.
The interplay between the Trx system and regulation of PTEN activity is likely to be complex. PTEN is a redox 
sensitive phosphatase, which becomes inactivated upon exposure to H2O2 and formation of a disulfide bond 
between Cys71 and Cys12433,34. Trx1 has been shown to reduce and reactivate this type of oxidized PTEN33,34. 
However, another study found that the reduced form of Trx1 directly binds to PTEN to inhibit its activity32. 
We showed previously, and also here, that the Trx1 protein becomes upregulated in Txnrd1−/− MEFs, which 
can at least in part be due to Nrf2 activation15. Importantly, here we show that Trx1 can be maintained in its 
reduced form also in the absence of TrxR1 and regardless of the state of adipocyte differentiation. Since GSH and 
Grx can constitute a backup system for Trx1 reduction when TrxR1 becomes impaired14,47,48, especially with the 
GSH-dependent enzyme systems being upregulated in the Txnrd1−/− MEFs15, this results in the apparent paradox 
that the levels of reduced Trx1 can become higher than normal in TrxR1 knockout cells. As our immunoprecip-
itation experiments suggested a stronger interaction between Trx1 and PTEN in Txnrd1−/− cells, this would be 
compatible with the notion of Trx1 binding to and serving as an inhibitor of PTEN32. The attenuated adipocyte 
differentiation seen upon overexpressed PTEN in the Txnrd1−/− MEFs further supports this model.
Primary MEFs are normally able to differentiate in vitro upon induction using treatment with pro-adipogenic 
factors3,49, whereas most immortalized MEFs have lost the capacity to differentiate3,49. Here we showed that the 
basal levels of TrxR activity in the parental immortalized Txnrd1fl/fl MEFs are two-fold higher than in primary 
MEFs. Upon long time treatment with proadipogenic factors, primary MEFs could differentiate into the adipo-
cyte lineage, but the immortalised Txnrd1fl/fl MEFs could not, consistent with our findings that TrxR1 suppresses 
adipocyte differentiation. With Txnrd1 depletion restoring and enhancing the adipocyte differentiation capacity 
of immortalised MEFs, this became a vivid illustration of the importance of TrxR1 for regulation of adipogen-
esis in MEFs. Interestingly, the Txnrd1−/− MEFs seemed to differentiate into brown-like or beige adipocytes, as 
reflected by increased UCP1 expression3,50. Thus, TrxR1 may possibly also play specific roles in regulation of 
white vs beige adipocyte differentiation, which should clearly be studied further.
To understand the mechanisms underpinning the increased adipogenesis in Txnrd1−/− MEFs, it is important 
to note that MCE is considered essential for adipogenesis of MEFs and 3T3-L1 cells17,18. As the Txnrd1fl/fl MEFs 
were unable to undergo MCE, this could be a main reason for their inability to differentiate into adipocytes. It was 
in this context interesting that TrxR1 deficient MEFs spontaneously underwent MCE, with hormonal inducers 
further augmenting the process. As shown before, and also found here with regards to lipid peroxidation, deple-
tion of Txnrd1 in MEFs leads to a heightened oxidative stress15. Increased production of H2O2 can be detrimental 
if excessive, but can facilitate adipocyte differentiation through enhancement of signal transduction and accelera-
tion of MCE35,51,52. Increased H2O2 levels helping to trigger adipogenesis is compatible with our findings that sup-
plementation with antioxidants inhibited adipocyte formation. It was particularly intriguing that NAC completely 
abrogated adipocyte differentiation, partially through blocking of the MCE. One possible part of that effect could 
involve increased p27 levels, as p27 is well known to be a crucial protein regulated by oxidative events and causing 
cell cycle arrest53,54. Downregulation of p27 is also tightly connected to Akt activation39,55, which agrees with our 
findings in the Txnrd1−/− MEFs. Activated Akt phosphorylates p27 at threonine 157, which localizes p27 to the 
cytosol and leads to proteasomal degradation39,56. Akt also phosphorylates FOXO3a and inhibits its transactiva-
tion of p27 expression55. As NAC treatment blocked Akt activation in the knockout cells, it appears that oxidative 
stress can contribute to Akt activation in these cells, as shown earlier in other cell types57,58.
The importance of PPARγ in relation to our findings should be its ligand-mediated activation and pluri-
potent roles in adipogenesis59. Nitro-modified unsaturated fatty acids are endogenous PPARγ ligands acting at 
sub-micromolar concentration40, of which the production becomes facilitated by increased oxidative stress41. As 
we detected higher lipid peroxidation levels in the Txnrd1−/− MEFs compared to the Txnrd1fl/fl cells, this suggests 
that more nitro-modified unsaturated fatty acids are indeed produced in the knockout cells, which subsequently 
may activate PPARγ . Indeed, DMI treatment without inclusion of the PPARγ ligand rosiglitazone could still acti-
vate PPARγ and upregulate FABP4/aP2 expression in those cells, indicating that there must be an endogenously 
increased PPARγ ligand production in Txnrd1−/− cells. Since we further found that addition of AONO2 could 
promote adipocyte formation and that NAC could bind nitrated fatty acids directly in vitro, such scavenging may 
well have been another mechanism to explain the complete NAC blockage of the adipocyte differentiation that 
we observed.
In conclusion, our findings demonstrate that depletion of Txnrd1 promotes adipocyte differentiation of 
immortalized MEFs. This occurs through enhanced responsiveness to insulin signaling, with attenuated PTEN 
activity, loss of cell cycle control by activation of Akt, downregulation of p27, and activation of PPARγ . Our 
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observations that TXNRD1 transcript levels inversely associate with clinical signs of human insulin resistance 
in vivo and in adipocytes in vitro warrant further studies addressing the potential role of TrxR1 as a therapeutic 
target in diseases affecting glucose and/or lipid metabolism. As suggested here, TrxR1 is as important modulator 
of cell fate and metabolism through suppression of insulin signaling and adipocyte differentiation.
Materials and Methods
Materials. The expression plasmid encoding wildtype (wt) PTEN (catalog number 10750) and mutant C124S 
PTEN (10744) with the control empty plasmid were all from Addgene (Cambridge, MA, USA) and have been 
described elsewhere60. 9-Nitrooleate (AONO2) and 10-Nitrolinoleate (LNO2) were purchased from Cayman 
Chemical (Ann Arbor, MI, USA). All chemicals were obtained from Sigma-Aldrich Chemicals (St. Louis, MO, 
USA) unless stated otherwise.
Ethics. Studies in humans were approved by the regional ethical review board of Stockholm (Regionala 
Etikprövningsnämnden i Stockholm) and were conducted in full accordance with the Declaration of Helsinki. 
Informed written consent was obtained from all participants. Patient cells were obtained under ethical permit 
nr. 326/03 and array analyses were performed under ethical permit nr. 2011/1002-31/3. The mouse embryonic 
fibroblasts (MEFs) were isolated in Munich, Germany, in accordance with the German Animal Welfare Law 
and approved by the institutional committee on animal experimentation and the government of Upper Bavaria, 
Germany, under statements nr. VII 7/8730-1/6/99 and 211-2531.1-19/04.
MEFs cell cultures and adipocyte differentiation. The establishment of wildtype TrxR1 expressing 
parental MEFs having exon 15 of the Txnrd1 gene flanked by flox sites (Txnrd1fl/fl) and the full TrxR1 knockout 
MEFs derived from Txnrd1fl/fl cells after Cre treatment in vitro (hereafter referred to as Txnrd1−/−) were previ-
ously described15. The MEFs were kept at >10% confluence (split 1:8 or less for culture maintenance) in DMEM 
with 4.5 g/l glucose content, supplemented with 4 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin 
(BioWhittaker, Lonza, NJ, USA) and 10% (v/v) fetal bovine serum (PAA Laboratories, Piscataway, NJ, USA). 
No extra selenium source was added unless mentioned. Cells were grown in humidified air containing 5% CO2 
at 37 °C for all experiments. Primary MEFs were isolated from pregnant mice at day 13.5 post coitum. Single 
cells were obtained by shaking (100 rpm) for 15 minutes at 37 °C with 0.05% trypsin/EDTA (Invitrogen), DNase 
(100 U/ml, Roche) and glass pearls. The reaction was stopped by adding medium with 10% FCS. Cells were then 
cultured in DMEM medium mentioned above with 0.2% gelatin-coated flask. To induce differentiation, 2-day 
postconfluent MEFs (designated day 0) were cultured in DMEM containing 10% FBS, 1 μ M dexamethasone, 
0.5 mM methylisobutylxanthine, 5 μ g/ml insulin and 0.5 μ M rosiglitazone, unless stated otherwise. From day 2, 
medium containing 5 μ g/ml insulin and 0.5 μ M rosiglitazone was changed every other day until day 8 or as 
indicated.
TXNRD1 knockdown and adipocyte differentiation in primary human pre-adipocytes. Human 
adipose tissue was obtained from adult human subjects undergoing surgery for non-malignant conditions. 
Although both donors were anonymous to us, they had given informed written consent to donate tissue that 
would have otherwise been discarded. The study was approved by the regional board of ethics. Human adi-
pose tissue-derived stromal vascular cells were isolated as previously described61 and cultured in 12-well format 
as previously described62 with one exception; differentiation was induced 48 h instead of 24 h after plating in 
order to downregulate TXNRD1 prior to initiation of adipogenesis. Gene expression of TXNRD1, which encodes 
TrxR1 in human, was knocked down using siRNA (sense 5′ -(GCAAGACUCUCGAAAUUAU)dTdT-3′ , anti-
sense 5′ -(AUAAUUUCGAGAGUCUUGC)dAdG-3′ ). Control cells were transfected with Allstars negative con-
trol (Qiagen, Hilden, Germany). In all cells, transfections were performed using HiPerFect transfection reagent 
(Qiagen, Hilden, Germany) with 20 nM siRNA at two time points, 24 h and 48 h after plating. Differentiated cells 
were stained with Oil Red-O as described below 12–14 days after plating.
Oil Red-O staining. Cells were washed three times with PBS (Phosphate-buffered saline) and then fixed with 
4% formaldehyde for 1 h. Oil Red-O (0.3% in isopropanol) was diluted with water (3:2), filtered through a 0.22 μ m 
filter, and incubated with the fixed cells for 30 min at room temperature. Cells were then washed with water, 
whereupon stained neutral fat droplets were visualized by light microscopy and photographed. Oil Red-O was 
thereafter extracted using isopropanol and absorbance was measured at 570 nm for quantification.
Triglyceride measurement. The cells were seeded on 150 mm dishes and cultured for 4 days to reach con-
fluence. Triglyceride contents were then measured using a Triglyceride Quantification Kit (ab65336, Abcam, 
Cambridge, UK) according to the instruction manual.
Glycogen measurement. The cells were seeded on 150 mm dish and cultured for 4 days to reach conflu-
ence. Glycogen contents were measured using a Glycogen Assay Kit II (#ab169558; Abcam, Cambridge, MA, 
USA) according to the manufacturer’s guidelines.
Lactate production. The assessment of lactate production as an indication of glycolytic flux was performed 
as previously described with slight modifications63. Cells were seeded in M12 well plates, at a density of 50× 10E5 
cells per well. The day after, the cells were changed to DMEM containing 2% FBS and 5 mM glucose or 25 mM glu-
cose. Then 50 ul of media were collected at 4 h, 6 h and 8 h for analysis. At the end of the experiment, the cells were 
lysed (see protocol below for cell lysis) and the total amount of protein was determined for normalization. The 
amount of lactate present in the media was determined using the LACT (Lactate) reagent from Beckman Coulter 
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(Brea, CA, USA), according to the manufacturer’s guidelines. An additional well per condition was ran in paral-
lel with the glycolytic competitive inhibitor 2-deoxyglucose (30 mM; Sigma-Aldrich, St. Louis, MO, USA). The 
amount of lactate generated in the presence of 2-deoxyglucose represents the non glycolytic-derived lactate, and 
was therefore substracted from the overall lactate production. The depicted results represent glycolysis-derived 
lactate production.
Measurement of cellular oxygen consumption. Oxygen consumption rate (OCR) in real time on MEFs 
was performed using an Extracellular Flux Analyzer X24-3 (Seahorse Bioscience, Billerica, MA, USA) as previ-
ously described63. Cells were seeded at a density of 50x 10E3 cells/well. For the experiment the cells were changed 
to bicarbonate- and FBS-free DMEM medium (Sigma). The sequential addition of the mitochondrial ATP syn-
thase inhibitor oligomycin (1 uM; EMD Millipore, Billerica, MA, USA), the uncoupling ionophore carbonyl cya-
nide 4-trifluoromethoxyphenylhydrazone (FCCP; 0.5 uM; Sigma-Aldrich) and the mitochondrial complex III 
inhibitor antimycin A (5 uM; Sigma-Aldrich) allowed us to determine the fraction of respiration coupled to ATP 
production, the maximal respiratory capacity and the unproductive respiration not coupled to ATP production, 
also known as “leak”64.
Analysis of mitochondrial mass in MEFs. Txnrd1fl/fl and Txnrd1−/− MEFs were seeded onto M24 wells 
and cultured for 1 day. The cells were then incubated with 500 nM of MitoTracker Green (Life Technologies, 
Grand Island, NY, USA) for 15 min at 37 °C, washed twice with culture medium, and visualized using a Zeiss 
Axiovert 40 CFL fluorescent microscope (Zeiss, Overkochen, Germany), photographed with a coupled Zeiss 
Axiovert ICm1 camera. Fluorescence intensity was analyzed using the AxioVs40 v4.8.2.0 (Zeiss) and ImageJ 
v1.48 softwares. All samples were processed in parallel and images captured in the same session using the same 
imaging parameters. At least 500 cells per well and 3 wells per genotype were quantified for analysis. Data were 
expressed as Relative Fluorescent Units.
Glucose uptake. Cells were seeded at a density of 1.5 × 105 cells/well in M6-well plates, and they were allowed 
to recover over night. Cells were starved for 5 hours in DMEM without glucose, glutamine, pyruvate nor FBS for 
5 hours. The medium was then replaced by fresh medium containing 5 ug/ml insulin, and the cells were incubated 
for 1 hour in this medium. The medium was then replaced with 1 ml of medium per well containing 5 μ g/ml 
insulin, 10 μ M 2-deoxyglycose (Sigma-Aldrich, St. Louis, MO, USA) and 1 μ Ci (20 nM) 3H-2-deoxyglucose 
(American Radiolabeled Chemicals, Inc., St. Louis, MO, USA). Cytochalasin B (Sigma-Aldrich) was used 
to inhibit insulin-independent glucose transport. Cells were allowed to uptake labeled 2-deoxyglucose for 
select periods of time (10, 20 and 30 minutes), and then they were extensively washed with chilled PBS and 
lysed in ice-cold 0.4 N NaOH. The lysates were mixed with Emulsifier Safe Scintillation liquid (Perkin-Elmer, 
Waltham, MA, USA) and 2-deoxyglucose uptake was quantified using a scintillation counter. Data were deter-
mined as counts per minute (CPM) and calculated in 2-deoxyglucose concentration using a known standard of 
3H-2-deoxyglucose, and normalized by total amount of protein.
Antibodies. Antibodies against PPARγ (E-8), C/EBPα (14AA), C/EBPβ (C-19), insulin Rβ (C–19), 
p-Tyr (PY99), p27 (F-8), cyclin A (H-432), cyclin E (M-20), and GAPDH (FL-335) were from Santa Cruz 
Biotechnologies, Inc. (CA, USA). Antibody against FABP4/aP2 (ab66682) was obtained from Abcam Inc. 
(Cambridge, MA, USA). Antibodies against phospho-Akt (Thr308) (9275), Phospho-Akt (Ser473) (9271), 
Akt (9272), phospho-CREB (Ser133) (9191), phospho-S6 (Ser235/Ser236) (4858), S6 (2217), PTEN (9552) 
came from Cell Signaling Technology, Inc. (Danvers, Ma, USA). The antibodies against β -Actin (#A5441) and 
Voltage-Dependent Anion Channel-1 (VDAC1; #PC548) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) and EMD-Millipore, respectively. Anti-mouse Trx1 antibody serum was a kind gift from Dr. Gary Merrill 
(Oregon State University, Corvallis, OR, USA).
Enzyme activity assays. Cellular TrxR activity was measured using end-point insulin reduction assay. 4 μ g 
total cellular protein was incubated with 20 μ M recombinant human wt Trx, 297 μ M insulin, 1.3 mM NADPH, 
85 mM Hepes buffer, pH 7.6, and 13 mM EDTA for 80 min at 37 °C, in a total volume of 50 μ l. The reaction was 
then terminated by adding 200 μ l of 7.2 M guanidine-HCl in 0.2 M Tris-HCl, pH 8.0, containing 1 mM DTNB. 
The extent of Trx-dependent formed thiols in the reduced insulin was then determined by measuring absorbance 
at 412 nm (extinction coefficient 13,600 M−1 cm−1) and subtracting a background absorbance for each sample 
incubated and treated in the same manner containing all components except Trx.
Immunoblot. Cells were harvested and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM 
EDTA, 1 mm EGTA, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% SDS, 0.5 mM PMSF, 1.2 mg/ml protease 
inhibitor cocktail (Roche, Basel, Switzerland), phosphatase inhibitor cocktail 3 (Sigma-Aldrich). The supernatants 
clarified after centrifugation (13300 r.p.m., 15 min) were used and total protein concentrations were determined 
with a Bradford reagent kit (Bio-Rad, Hercules, CA, USA). Protein lysates were subjected to SDS/PAGE and 
transferred onto nitrocellulose membrane using iBlot Dry Blotting System (Thermo Fisher Scientific, Waltham, 
MA, USA). For detection, the SuperSignal West Pico kit (Thermo Fisher Scientific, Waltham, MA, USA) was used 
according to the manufacturer’s instructions, with signals detected utilizing a Bio-Rad ChemiDoc XRS scanner 
and the Quantity One 4.6.7 software.
Immunoprecipitation. Cells were harvested and lysed in RIPA buffer as described above. First the primary 
rabbit antibody (2 μ g) was pre-incubated with 50 μ l of Dynabeads sheep anti rabbit IgG (Life Technologies, Grand 
Island, NY, USA) with gentle shaking for 3 hours at 4 °C. Total cell lysate (1 to 2 mg protein) was then added into 
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the mixture and incubated with gentle rocking overnight at 4 °C. After several washes of the beads in PBS con-
taining 0.1% BSA and 2 mM EDTA, loading buffer was added to the samples and then they were boiled. Finally 
proteins in the supernatants were separated on 12% SDS–PAGE, transferred and probed. TrueBlot anti-rabbit IgG 
(Rockland Immunochemicals, Gilbertsville, PA, USA) was here used as secondary antibody.
Quantitative Real time-PCR. Total RNA was isolated using the RNAeasy mini kit (Qiagen, Limburg, 
Netherlands) according to the manufacturer’s protocol. Total RNA (2 μ g) was reverse transcribed using Maxima 
First Strand cDNA synthesis kit (Thermo Fisher Scientific, Waltham, MA, USA) and random hexamer primers. 
QRT-PCR was performed using Maxima SYBR Green qPCR Master Mix (Thermo Fisher Scientific, Waltham, 
MA, USA) on PikoReal 96 real time PCR system (Thermo Fisher Scientific, Waltham, MA, USA). The read-
outs for the mRNA levels of specific genes were normalized to 18S as housekeeping control. Specific primers 
were designed and synthesized (Thermo Fisher Scientific, Waltham, MA, USA) as follows: mouse p27: sense, 
5′ -CAGCTTGCCCGAGTTCTACT-3′ ; antisense, 5′ -GAGTTTGCCTGAGACCCAAT-3′ ; mouse cyclin E: sense, 
5′ -CCCTTAAGTGGCGTCTAAGC-3′ ; antisense, 5′ -TACTGAGGCATCAGCACCTC-3′ ; mouse PPARγ : sense, 
5′ -ATCTTAACTGCCGGATCCAC-3′ , antisense, 5′ -GATGGCATTGTGAGACATCC-3′ ; mouse 18S: sense, 
5′ -ACCGCAGCTAGGAATAATGGA-3′ ; antisense, 5′ -GCCTCAGTTCCGAAAACCA-3′ ; human TrxR1: sense, 
5′ -ATATGGCAAGAAGGTGATGGTCC-3′ ; antisense, 5′ -GGGCTTGTCCTAACAAAGCTG-3′ ; human LRP10: 
5′ -sense GATGGAGGCTGAGATTGTG-3′ ; antisense, 5′ -GAGTCATATCCTGGCGTAAG-3′ .
Free thiol determination. NAC (130 μ M) was incubated with different concentrations of AONO2, LNO2 
or Rosiglitazone as indicated for 30 min in PBS buffer in a 96 well plate. Then free thiols of NAC were quantified 
by adding 2 mM DTNB and absorbance was measured at 412 nm. The amount of free thiol was calculated using 
Beer-Lambert law and 14,150 M−1 cm−1 was used as the extinction coefficiency of TNB− 65.
Assessment of lipid peroxidation. Txnrd1fl/fl and Txnrd1−/− MEFs were cultured to confluence, with the 
Txnrd1−/− MEFs incubated with or without 100 μ M α -tocopherol for two days. The cells were then stained with 
5 μ M Bodipy (581/591) at 37 °C for 30 min. Cells were collected and fixed with 0.5% paraformaldehyde in PBS. 
Signals were analyzed using FACScan with the FITC channel and a total of 10000 cells of each sample were 
counted.
Redox immunoblotting of Trx1. Redox immunoblotting was performed based on an electrophoretic 
mobility-shift assay47. Briefly, the cells were lysed with a sample solution (50 mM Tris–HCl, 1 mM EDTA, 8 M 
urea, pH 8.3) containing 30 mM iodoacetic acid (IAA). After incubation at 37 °C for 30 min, the proteins were pre-
cipitated and washed with ice-cold acetone/1 M HCl (98/2 v/v) three times. Then the precipitate was resuspended 
in the sample solution containing 3.5 mM dithiothreitol (DTT) and incubated at 37 °C for 30 min. Subsequently, 
the proteins were alkylated with 10 mM iodoacetamide (IAM) and separated by PAGE in buffer containing 8 M 
urea and transferred onto nitrocellulose membrane using iBlot Dry Blotting System (Thermo Fisher Scientific, 
Waltham, MA, USA). Trx1 was detected using immunoblotting with antibodies against mouse Trx1. Form of 
Trx1 having more free thiols became more negatively charged by alkylation with IAA and thus migrated faster.
ATP Levels. Cells were seeded at a density of 104 cells/well in M96-well plates, and ATP levels were deter-
mined using the Cell Titer Glo reagent from Promega (Madison, WI, USA), according to the guidelines provided 
by the manufacturer, and expressed as relative luminescence units (RLU) and normalized by total amount of 
protein.
Human Data. Data on TXNRD1 expression in subcutaneous abdominal adipose tissue was retrieved from a 
previously described cohort of 26 non-obese and 30 obese women analyzed by gene micro-array (Human Gene 
1.0 ST Array, Affymetrix Inc., Santa Clara, CA)43. Global transcription profiling data have been described and are 
deposited at the National Center for Biotechnology Information Gene Expression Omnibus (http://ncbi.nim.nih.
gov/geo) under the accession number GSE2540243.
Insulin sensitivity in vivo was determined by a short insulin tolerance test as previously described66. Briefly, 
plasma glucose levels after intravenous insulin injection were determined and plotted in a semilogaritmic graph. 
The rate constant (k) derived from this plot represented the intravenous insulin tolerance (KITT) and was 
expressed as the % fall in glucose/min between 4 and 16 minutes. Plasma triglycerides (TGs) were determined by 
the hospital’s accredited clinical chemistry laboratory.
Lipogenesis in isolated fat cells was performed as described in detail previously67. In brief, isolated fat cells 
were incubated for 2 hrs at 37 °C in a buffer containing unlabelled glucose and 3H-glucose without or with increas-
ing concentrations of insulin. After incubation, lipids were extracted and radioactive glucose incorporation into 
total lipid was used as an index of lipogenesis. The ability of insulin to stimulate lipogenesis at maximum effective 
concentration was expressed as nmol glucose/107 fat cells* 2 hrs.
Adiponectin secretion from intact adipose tissue was determined in conditioned media (100 mg tissue/1 ml 
of medium) as described before68 except that an ELISA assay from Mercodia (Uppsala, Sweden) was used for the 
analyses69. Results were expressed as ng/107 fat cells* 2 hrs.
Statistics. Values are presented as means ± S.E.M. Statistical evaluation was performed with the Mann–
Whitney test using the GraphPad Prism software, version 5.0 (GraphPad Software, San Diego, CA, USA) or 
multiple regression using JMP (12.1 SAS Institute Inc., Cary, NC, USA). Non-normally distributed parameters 
were log10 transformed as indicated. Asterisks or pound signs denote statistically significant differences between 
the indicated groups of data (n.s. no significant; * or #P < 0.05; * * or ##P < 0.01; * * * or ###P < 0.001).
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